SRSF2 and malignant colon neoplasm: The restoration of SLMAP-L or CETN3-S but not SLMAP-S and CETN3-L, efficiently reversed the effects of SRSF2 knockdown on the proliferation of colon cancer cells (Figs. 8, B–F and S8, B and C).